1370025-54-9

Basic information

• Product Name: 2-BroMo-6-fluoro-4-Methylbenzaldehyde
• Synonyms: 2-BroMo-6-fluoro-4-Methylbenzaldehyde
• CAS NO: 1370025-54-9
• Molecular Formula: C₈H₆BrFO
• Molecular Weight: 217.0350432
• Mol File: 1370025-54-9.mol

Chemical Properties

• Boiling Point: 253.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.575±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-BroMo-6-fluoro-4-Methylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BroMo-6-fluoro-4-Methylbenzaldehyde(1370025-54-9)
• EPA Substance Registry System: 2-BroMo-6-fluoro-4-Methylbenzaldehyde(1370025-54-9)

Safety Data

• Hazardous Substances Data: 1370025-54-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-6-fluoro-4-methylbenzaldehyde serves as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and medicinal compounds. Its unique chemical structure allows it to be a key component in the creation of therapeutic agents.
Used in Organic Compounds Synthesis:
2-BroMo-6-fluoro-4-Methylbenzaldehyde is utilized as an intermediate in the synthesis of other organic compounds, playing a crucial role in the production of various chemical products.
Used in Dye Production:
2-Bromo-6-fluoro-4-methylbenzaldehyde is employed in the production of dyes, where its chemical properties contribute to the color and stability of the final product.
Used in Fragrance Industry:
In the fragrance industry, this compound is used to create unique scents and perfumes, capitalizing on its aromatic properties to enhance the olfactory experience.
Used in Other Industrial Applications:
Beyond the aforementioned uses, 2-Bromo-6-fluoro-4-methylbenzaldehyde finds application in various other industrial sectors, leveraging its chemical characteristics for diverse purposes.

Upstream product

• 50-00-0 formaldehyd 
• 18349-09-2 2-bromo-6-fluoro-4-methyl aniline 
• 202865-83-6 1-bromo-3-fluoro-5-methylbenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 452-80-2 2-fluoro-4-methylaniline 
• 1068-55-9 isopropylmagnesium chloride 
• 824-54-4 2-bromo-4-methylbenzaldehyde 

Downstream Products

• 1377934-89-8 methyl 1-[3-bromo-5-fluoro-4-(1-methoxy-1-oxopropane-2-yl)benzyl]-2-oxocyclopentanecarboxylate 
• 1377934-90-1 2-[2-bromo-6-fluoro-4-{(2-oxocyclopentyl)methyl}phenyl]propanoic acid 
• 1023971-89-2 2-bromo-6-fluoro-4-methylbenzonitrile 

Relevant articles and documents

Dihydroisocoumarin derivative and preparation method and application thereof

The present invention discloses a dihydroisocoumarin derivative and preparation method and application thereof, the dihydroisocoumarin derivative having a structure as shown in formula (I) or (II). The method of preparing dihydroisocoumarin derivatives of

Pd-Catalyzed, ortho C-H Methylation and Fluorination of Benzaldehydes Using Orthanilic Acids as Transient Directing Groups

The direct, Pd-catalyzed ortho C-H methylation and fluorination of benzaldehydes have been accomplished using commercially available orthanilic acids as transient directing groups. In these reactions, the 1-fluoro-2,4,6-trimethylpyridinium salts can be either a bystanding F+ oxidant or an electrophilic fluorinating reagent. An X-ray crystal structure of a benzaldehyde ortho C-H palladation intermediate was obtained using triphenylphosphine as the stabilizing ligand.

CARBOXY SUBSTITUTED (HETERO) AROMATIC RING DERIVATIVES AND PREPARATION METHOD AND USES THEREOF

Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.

(AZA)PYRIDOPYRAZOLOPYRIMIDINONES AND INDAZOLOPYRIMIDINONES AS INHIBITORS OF FIBRINOLYSIS

The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.

(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use

The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.

Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2- oxocyclopentyl)methyl]phenyl}propanoic acid: Nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity

We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properti